Protective Effects of Kampo Medicines and Baicalin against Intestinal Toxicity of a New Anticancer Camptothecin Derivative, Irinotecan Hydrochloride (CPT‐11), in Rats

In clinical use, irinotecan hydrochloride (CPT‐11; 7‐ethyl‐10‐[4‐(piperidmo)‐l‐piperidino]carbonyl‐oxycamptothecin), a novel antitumor agent, causes a relatively high incidence of severe forms of diarrhea. We investigated whether baicalin, an inhibitor of β‐glucuronidase, which deconjugates the gluc...

Descripción completa

Detalles Bibliográficos
Autores principales: Takasuna, Kiyoshi, Kasai, Yoshio, Kitano, Yutaka, Mori, Kazuhiko, Kobayashi, Reiko, Hagiwara, Takehiro, Kakihata, Kohji, Hirohashi, Masaaki, Nomura, Mamoru, Nagai, Eiichi, Kamataki, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1995
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920598/
https://www.ncbi.nlm.nih.gov/pubmed/7493918
http://dx.doi.org/10.1111/j.1349-7006.1995.tb03010.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920598/
https://www.ncbi.nlm.nih.gov/pubmed/7493918
http://dx.doi.org/10.1111/j.1349-7006.1995.tb03010.x

Ejemplares similares